Migration to Scale-up implies that the results of the Feasibility Study met or exceeded the prospective client's expectations.

Prior to entering into the Scale-up study, Radient and the prospective client typically agree upon and execute a negotiated Letter of Intent that, assuming the successful conclusion of the Scale-up study, would provide the terms for establishing a long term exclusive supply or license agreement.

The objective of the Scale-up study is to replicate the Feasibility study results at a more significant scale in Radient's production plant.  Scale-up allows for optimization and expansion of targets to include primary and secondary product attributes necessary for market success. Specifically, Scale-up tests involve processing a larger volume of the client's source material and delivery of the resulting target compound that meets the client's specifications in all regards to demonstrate Radient's ability to process at commercial volumes. A Scale-up will typically take 10-12 weeks to complete from receipt of the raw material through providing the prospective client with the Scale-up report.